Related by context. Frequent words. (Click for all words.) 59 R sorafenib tablets 58 plus prednisone 57 plus gemcitabine 57 refractory chronic lymphocytic 56 relapsed refractory multiple myeloma 55 #mg/m# [002] 55 platinum refractory 54 forodesine 54 HGS ETR2 54 liposomal formulation 54 Coadministration 53 multi kinase inhibitor 53 Daclizumab 53 refractory multiple myeloma 53 HGS ETR1 52 metastatic castration resistant 52 metastatic castrate resistant 52 recurrent glioblastoma multiforme 52 Initiates Phase II 51 Meets Primary Endpoint 51 Phase Ib II 51 ThermoDox R 51 Pivotal Phase III 51 KRN# 51 ongoing Phase 1b 50 tumor lysis syndrome 50 Single Dose 50 mg/m2 50 ascending doses 50 phase Ib 50 CR# vcMMAE 49 Initiates Phase 49 randomized Phase III 49 MKC# 49 R bortezomib 49 dose escalation clinical 49 Relapsed 49 IMC #B 49 Receives Orphan Drug Designation 49 Monotherapy 48 post herpetic neuralgia PHN 48 HALTS 48 Sapacitabine 48 Randomised 48 phase IIb clinical 48 label multicenter 48 Pivotal Phase 48 Completes Enrollment 47 Metastatic Colorectal Cancer 47 YOUR LOCAL ANIMAL SHELTER 47 celgosivir 47 intraperitoneal 47 IIa trial 47 Epratuzumab 47 carbidopa 47 pulmonology portfolio 46 double blinded placebo 46 dose escalation trial 46 multicenter Phase 46 Improves Survival 46 oral corticosteroids 46 Phase III Trial 45 Chronic Hepatitis C 45 Initiate Phase 45 Tesetaxel 45 Phase III Clinical Trial 45 Enrolls First 45 Commences Phase 45 SUCCEED trial 45 Pivotal Trial 45 placebo controlled Phase 45 Dapagliflozin 45 inspect vials 44 Pralatrexate 44 II Clinical Trial 44 Phase Ib clinical 44 Fibrillex TM 44 pseudobulbar affect PBA 44 Microplasmin 44 Myelofibrosis 44 Phase 2a clinical 44 Presents Positive 44 J Am Acad 44 Diabetic Macular Edema 44 registrational trial 43 Renal Cell Carcinoma 43 Pivotal Study 43 Pirfenidone 43 multicenter prospective 43 Phase IIIb 43 Involuntary manslaughter carries 43 FDA Accepts 42 virologic failure 42 TACI Ig 42 registrational 42 Metastatic Melanoma 42 Phase 2b study 42 Clinical Trial Results 42 Phase 1b clinical 41 multicenter clinical 41 Patient Enrollment